Each filer's latest filing for G4690M101 since 12/18/2024, largest first.
| Filer | % of Class | Filed | ||
|---|---|---|---|---|
| Under 5%, checked the "5 percent or less" box, or amended by a later filing (3) | ||||
|
PineBridge GEM II G.P., L.P.
13D/A
|
3.9% |
2/27/2025
Event 2/25/2025
|
||
| PineBridge Global Emerging Markets Partners II, L.P. | 3.9% | |||
| PineBridge GEM II G.P., L.P. | 3.9% | |||
| Leone John | 3.9% | |||
| Mellinger Pierre | 3.9% | |||
| Clowe Kevin | 3.9% | |||
|
American Century Investment Management, Inc.
13G/A
|
3.8% |
8/14/2026
Event 6/30/2026
|
||
| American Century Investment Management, Inc. | 3.8% | |||
| American Century Companies, Inc. | 3.8% | |||
| Stowers Institute for Medical Research | 3.8% | |||
| JPMorgan Chase & Co 13G/A | 2.9% |
5/5/2025
Event 4/30/2025
|
||
| Period | Filers | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 51 | 1.73 M | $74.8 M |
| 2026 Q2 | 153 | 10.4 M | $317 M |
| 2026 Q1 | 167 | 10.4 M | $278 M |
| 2025 Q4 | 173 | 10.3 M | $393 M |
| 2025 Q3 | 155 | 10.5 M | $423 M |
| 2025 Q2 | 143 | 10.1 M | $295 M |
| 2025 Q1 | 144 | 9.96 M | $242 M |
| 2024 Q4 | 118 | 8.15 M | $175 M |
| 2024 Q3 | 96 | 6.59 M | $131 M |
| 2024 Q2 | 73 | 6.57 M | $106 M |
| 2024 Q1 | 75 | 6.60 M | $102 M |
| 2023 Q4 | 84 | 12.4 M | $227 M |
| 2023 Q3 | 84 | 6.53 M | $101 M |
| 2023 Q2 | 91 | 6.56 M | $139 M |
| 2023 Q1 | 86 | 6.23 M | $151 M |
| 2022 Q4 | 64 | 5.44 M | $135 M |
| 2022 Q3 | 46 | 4.93 M | $91.5 M |
| 2022 Q2 | 46 | 4.84 M | $81.7 M |
| 2022 Q1 | 44 | 4.85 M | $77.1 M |
| 2021 Q4 | 41 | 4.96 M | $64.0 M |
| 2021 Q3 | 40 | 4.56 M | $77.5 M |
| 2021 Q2 | 39 | 4.46 M | $87.0 M |
| 2021 Q1 | 40 | 4.38 M | $96.3 M |
| 2020 Q4 | 42 | 4.40 M | $82.3 M |
| 2020 Q3 | 36 | 4.27 M | $65.6 M |